‌

US Patent 10682349 Lanthionine synthetase C-like 2-based therapeutics

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Landos Biopharma

Current Assignee

Landos Biopharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 16, 2020

Patent Application Number

16653446

Date Filed

October 15, 2019

Patent Citations

US Patent 10201538 Lanthionine synthetase C-like 2-based therapeutics

US Patent 10028950 Lanthionine synthetase C-like 2-based therapeutics

US Patent 10493072 Lanthionine synthetase C-like 2-based therapeutics

Patent Citations Received

US Patent 11492342 Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)

US Patent 11377437 Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same

Patent Primary Examiner

Emily A Bernhardt

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10682349 Lanthionine synthetase C-like 2-based therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool